创伤患者亲密伴侣与性暴力普遍筛查:EAST多中心试验
该研究为东部创伤外科协会(EAST)支持的多中心前瞻性观察队列,在美国4家一级创伤中心于2015年3月至2016年4月对成人创伤患者使用经验证的HITS和SAVE问卷进行普遍筛查。共筛查2034例 eligible 患者,平均年龄37.05±20.32岁,男性63%、女性37%、1例跨性别参与者。IPSV总体阳性率11.4%,男性9.3%(各中心间3.8-72.7%)、女性16.1%(15.3-50.0%)(p<0.001);IPSV阳性者中60.0%有至少一种创伤相关共病,阴性者中为15.1%(p<0.001)。作者认为IPSV可能是其他创伤相关共病的危险因素。
要点
- 在4家美国一级创伤中心对2034例成人创伤患者普遍筛查,IPSV总体阳性率11.4%,即超过九分之一创伤患者有IPSV风险。
- IPSV筛查阳性率男性9.3%、女性16.1%(p<0.001),且各中心间变异大(男性3.8-72.7%,女性15.3-50.0%)。
- IPSV筛查阳性者中60.0%有至少一种创伤相关共病(创伤再入院、物质使用、精神疾病),阴性者中为15.1%(p<0.001)。
- 筛查由各中心临床社会工作者使用经验证的HITS和SAVE问卷完成,研究期间为2015年3月至2016年4月。
适用人群与场景
- 美国4家一级创伤中心的成人创伤患者,不限制损伤机制与性别。
- 研究期间为2015年3月至2016年4月,共筛查2034例 eligible 创伤患者。
诊断标准与关键阈值
- 使用经验证的HITS(Hurt, Insult, Threaten, Scream)和SAVE(性暴力)筛查问卷进行普遍筛查。
- 创伤再入院、物质使用和精神疾病被归类为「创伤相关共病」并同时测量。
研究设计与关键结果
- 多中心前瞻性观察队列,美国4家一级创伤中心,2034例成人创伤患者,由临床社会工作者完成普遍筛查。
- IPSV总体阳性率11.4%;男性9.3%(中心间3.8-72.7%),女性16.1%(15.3-50.0%)(p<0.001);1例跨性别参与者筛查阳性。
- IPSV阳性者中60.0%有至少一种创伤相关共病,阴性者中为15.1%(p<0.001)。
- 平均年龄37.05±20.32岁,男性63%、女性37%。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察队列研究。
- 证据等级:预后/流行病学 level II;医疗管理 level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,超过九分之一创伤患者有IPSV风险,与性别或损伤机制无关。
- 作者认为,IPSV可能是其他创伤相关共病的危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A single-center trial recently demonstrated a prevalence of 14% of intimate partner and sexual violence (IPSV) among both male and female trauma patients, regardless of mechanism of injury. We aimed to determine if this phenomenon was similar to rates in other trauma centers by assessing the feasibility of universal screening and determining the prevalence and association of IPSV with other trauma-associated comorbidities.
METHODS: We designed an Eastern Association for the Surgery of Trauma-supported multicenter, prospective observational cohort study involving four Level I trauma centers throughout the United States. Screening occurred from March 2015 to April 2016. We performed universal screening of adult trauma patients using the validated HITS (Hurt, Insult, Threaten, Scream) and SAVE (sexual violence) screening surveys. Trauma recidivism, substance use, and mental illness were also measured and were classified as "trauma-associated comorbidities." Chi-squared test compared categorical variables with significance at p <0.05. Parametric data is presented as mean ± standard deviation.
RESULTS: A total of 2,034 eligible trauma patients were screened by clinical social workers at each site over 1 year. The mean age was 37.05 ± 20.32 with 63% men, 37% women, and one transgendered participant. The overall rate of IPSV was 11.4%. The proportion of positive screens for men was 9.3%, with variability between centers (3.8-72.7%), and for women was 16.1% (15.3-50.0%) (p < 0.001). The transgendered patient screened positive for IPSV. Of patients who screened positive for IPSV, 60.0% had one or more trauma-associated comorbidity compared to 15.1% of patients who screened negative (p < 0.001).
CONCLUSION: More than one in nine trauma patients is at risk of IPSV, regardless of gender or mechanism of injury. IPSV may be a risk factor for other trauma-associated comorbidities.
LEVEL OF EVIDENCE: Prognostic/Epidemiologic, level II; Care Management, level III.
参考来源
- Zakrison TL, Ruiz X, Gelbard R, et al. Universal screening for intimate partner and sexual violence in trauma patients: An EAST multicenter trial. J Trauma Acute Care Surg. 2017. PMID: 28426560. doi:10.1097/TA.0000000000001495
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。